Search
for
Sort by
Research 61–90 of 1000+
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- The effect of St John’s wort on the pharmacokinetics and metabolism of finasteride in man
- <i>In Vitro</i> Antibacterial and Antioxidant Activities, Pharmacokinetics, and <i>In Silico</i> Molecular Docking Study of Phytochemicals from the Roots of <i>Ziziphus spina-christi</i>
- Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics
- Topical Formulations Containing Finasteride. Part I: In Vitro Permeation/Penetration Study and In Vivo Pharmacokinetics in Hairless Rat
- Rp-HPLC Determination of Quercetin in a Novel D-α-Tocopherol Polyethylene Glycol 1000 Succinate Based SNEDDS Formulation: Pharmacokinetics in Rat Plasma
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Cloning of the human phenol sulfotransferase gene family: three genes implicated in the metabolism of catecholamines, thyroid hormones and drugs
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Drug eruptions in dermatology
- The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives
- Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
- Medical Treatment of Alopecia
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- Severe cutaneous adverse reactions to drugs
- Poor Therapeutic Response in Female Pattern Hair Loss: Mechanisms and a Practical Framework for Clinical Management
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- Pharmacokinetic studies of minoxidil
- The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
- Interaction of chronic ethanol exposure and finasteride: sex and strain differences
- Androgen antagonists in androgen target tissues
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Hair Growth Promoting Activity of Cedrol Nanoemulsion in C57BL/6 Mice and Its Bioavailability